Clinical trials Brief October 27, 2026, 10:03 AM ET

Bayer posts results of Phase 3 finerenone trial in CKD with type 1 diabetes

The study, completed with 242 participants, compared finerenone plus standard of care to placebo in people with chronic kidney disease and type 1 diabetes. Results were first posted on ClinicalTrials.gov on October 27, 2026.

Primary source

ClinicalTrials.gov results record, October 27, 2026

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

Read the source: A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes clinicaltrials.gov

By The Priority Review desk. Machine-summarized from the source above; not independently reported. How we use automation